Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 11, Issue 1, Pages 140
Publisher
Springer Nature
Online
2012-11-14
DOI
10.1186/1475-2840-11-140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists
- (2012) Sayuri N. Friedland et al. AMERICAN JOURNAL OF MEDICINE
- Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study
- (2012) Xuanqi An et al. Cardiovascular Diabetology
- High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)
- (2012) Hiroyuki Daida et al. Cardiovascular Diabetology
- Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
- (2012) Peter P Toth et al. Cardiovascular Diabetology
- Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
- (2012) Tamio Teramoto et al. Cardiovascular Diabetology
- The Controversies of Statin Therapy
- (2012) J. Wouter Jukema et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
- (2012) Alexander Tenenbaum et al. PLoS One
- log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males
- (2011) Michel P Hermans et al. Cardiovascular Diabetology
- Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
- (2011) Sandra N Verhagen et al. Cardiovascular Diabetology
- "The metabolic syndrome... is dead": These reports are an exaggeration
- (2011) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
- (2011) Michel P Hermans et al. Cardiovascular Diabetology
- Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome
- (2011) Barbara C Hansen et al. Cardiovascular Diabetology
- Pharmacological and non-pharmacological interventions to influence adipose tissue function
- (2011) Jan Westerink et al. Cardiovascular Diabetology
- Optimal pharmacotherapy to combat the atherogenic lipid triad
- (2011) M. John Chapman et al. CURRENT OPINION IN CARDIOLOGY
- Statins and the risk of new-onset diabetes
- (2011) David Preiss et al. CURRENT OPINION IN LIPIDOLOGY
- The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
- (2011) Robert Krysiak et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
- (2011) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
- (2010) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects
- (2010) Manoj Mathew et al. Cardiovascular Diabetology
- Comparative Study of Bezafibrate and Pravastatin in Patients With Coronary Artery Disease and High Levels of Remnant Lipoprotein
- (2010) Keita Sano et al. CIRCULATION JOURNAL
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- Antidiabetic Action of Bezafibrate in a Large Observational Database
- (2009) J. H. Flory et al. DIABETES CARE
- Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions
- (2009) Kay-Dietrich Wagner et al. PHARMACOLOGY & THERAPEUTICS
- The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
- (2008) Jean-Charles Fruchart et al. AMERICAN JOURNAL OF CARDIOLOGY
- Secondary Prevention With Bezafibrate Therapy for the Treatment of Dyslipidemia
- (2008) Ilan Goldenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia
- (2007) Makoto Ayaori et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation